Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$252K Sell
2,097
-9,183
-81% -$1.06M 0.17% 164
2025
Q4
$323K Buy
+11,280
New +$1.06M 0.22% 121
2024
Q3
Sell
-1,653
Closed -$207K 150
2024
Q2
$207K Sell
1,653
-746
-31% -$96.1K 0.22% 127
2024
Q1
$317K Buy
2,399
+402
+20% +$49.5K 0.34% 85
2023
Q4
$218K Buy
+1,997
New +$207K 0.27% 109

Other funds holding MRK

FSA Advisors's MRK Position: Q1 2026 in Review

FSA Advisors reduced its Merck (MRK) stake by 81% in Q1 2026, selling an estimated $1.06M and leaving 2,097 shares worth $252K. The position accounts for 0.17% of the portfolio, ranked #164.

FSA Advisors first reported a position in MRK in Q4 2023 and has held it in 5 quarters since. The position peaked at $323K in Q4 2025. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • FSA Advisors held 2,097 shares of Merck worth $252K as of Q1 2026.
  • FSA Advisors sold 9,183 Merck shares in Q1 2026, an estimated $1.06M.
  • Merck made up 0.17% of FSA Advisors's portfolio in Q1 2026, its #164 holding.
  • FSA Advisors first reported a position in Merck in Q4 2023 and has held it in 5 quarters since.
  • FSA Advisors's Merck position peaked at $323K in Q4 2025.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on FSA Advisors's 13F filing for Q1 2026, filed 6 May 2026.